Linear mixed modelling analyses | |||||||||
---|---|---|---|---|---|---|---|---|---|
Self-efficacy dimensions | N | Main effects | B | 95% CI | SE | DF | t | p | |
Lower | Upper | ||||||||
Optimism | 116 | Intercept | 2.09 | 1.58 | 2.61 | 0.26 | 127.12 | 8.02 |  < 0.001 |
 |  | Baseline Optimism | 0.54 | 0.44 | 0.65 | 0.05 | 112.82 | 10.08 |  < 0.001 |
 |  | Treatment | − 0.08 | − 0.41 | 0.25 | 0.17 | 178.88 | − 0.50 | 0.62 |
 |  | Time | − 0.05 | − 0.33 | 0.24 | 0.14 | 106.09 | − 0.32 | 0.75 |
 |  | Time*Treatment | − 0.08 | − 0.44 | 0.27 | 0.18 | 106.79 | − 0.46 | 0.65 |
Advocacy | 116 | Intercept | 3.05 | 2.53 | 3.57 | 0.26 | 124.13 | 11.57 |  < 0.001 |
 |  | Baseline Advocacy | 0.38 | 0.27 | 0.48 | 0.05 | 105.68 | 7.03 |  < 0.001 |
 |  | Treatment | − 0.12 | − 0.44 | 0.20 | 0.16 | 197.72 | − 0.74 | 0.46 |
 |  | Time | 0.04 | − 0.28 | 0.36 | 0.16 | 102.04 | 0.23 | 0.82 |
 |  | Time*Treatment | − 0.01 | − 0.41 | 0.39 | 0.20 | 103.00 | − 0.07 | 0.95 |
Coping | 115 | Intercept | 2.15 | 1.65 | 2.64 | 0.25 | 128.64 | 8.60 |  < 0.001 |
 |  | Baseline Coping | 0.50 | 0.39 | 0.61 | 0.06 | 115.19 | 8.94 |  < 0.001 |
 |  | Treatment | − 0.02 | − 0.35 | 0.32 | 0.17 | 170.10 | − 0.09 | 0.93 |
 |  | Time | 0.05 | − 0.23 | 0.33 | 0.14 | 104.35 | 0.33 | 0.74 |
 |  | Time*Treatment | − 0.15 | − 0.50 | 0.20 | 0.18 | 104.65 | − 0.85 | 0.40 |
Self-efficacy | 115 | Intercept | 2.15 | 1.68 | 2.61 | 0.23 | 123.54 | 9.15 |  < 0.001 |
 |  | Baseline Self-efficacy | 0.53 | 0.43 | 0.63 | 0.05 | 112.67 | 10.30 |  < 0.001 |
 |  | Treatment | − 0.08 | − 0.36 | 0.20 | 0.14 | 172.85 | − 0.55 | 0.59 |
 |  | Time | − 0.01 | − 0.24 | 0.22 | 0.12 | 103.95 | − 0.06 | 0.95 |
 |  | Time*Treatment | − 0.08 | − 0.37 | 0.21 | 0.15 | 104.66 | − 0.57 | 0.57 |